The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 11 2022
Historique:
received: 27 12 2021
accepted: 30 09 2022
entrez: 7 11 2022
pubmed: 8 11 2022
medline: 10 11 2022
Statut: epublish

Résumé

Androgen deprivation therapies aimed to target prostate cancer (PrCa) are only partially successful given the occurrence of neuroendocrine PrCa (NEPrCa), a highly aggressive and highly metastatic form of PrCa, for which there is no effective therapeutic approach. Our group has demonstrated that while absent in prostate adenocarcinoma, the αVβ3 integrin expression is increased during PrCa progression toward NEPrCa. Here, we show a novel pathway activated by αVβ3 that promotes NE differentiation (NED). This novel pathway requires the expression of a GPI-linked surface molecule, NgR2, also known as Nogo-66 receptor homolog 1. We show here that NgR2 is upregulated by αVβ3, to which it associates; we also show that it promotes NED and anchorage-independent growth, as well as a motile phenotype of PrCa cells. Given our observations that high levels of αVβ3 and, as shown here, of NgR2 are detected in human and mouse NEPrCa, our findings appear to be highly relevant to this aggressive and metastatic subtype of PrCa. This study is novel because NgR2 role has only minimally been investigated in cancer and has instead predominantly been analyzed in neurons. These data thus pave new avenues toward a comprehensive mechanistic understanding of integrin-directed signaling during PrCa progression toward a NE phenotype.

Identifiants

pubmed: 36344556
doi: 10.1038/s41598-022-21711-5
pii: 10.1038/s41598-022-21711-5
pmc: PMC9640716
doi:

Substances chimiques

Androgen Antagonists 0
Integrins 0
RTN4RL2 protein, human 0
Nogo Receptor 2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

18879

Subventions

Organisme : NCI NIH HHS
ID : P30 CA010815
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL154811
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA224769
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK127589
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA220446
Pays : United States
Organisme : NIH HHS
ID : R01 CA234162
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA211199
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA140043
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA163227
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA241486
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Breast Cancer Res Treat. 2013 Nov;142(2):341-53
pubmed: 24197660
Front Pharmacol. 2020 Sep 11;11:579068
pubmed: 33041823
J Mol Med (Berl). 2018 Apr;96(3-4):265-279
pubmed: 29327067
J Clin Invest. 1999 Jan;103(2):229-38
pubmed: 9916135
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436
pubmed: 31061129
J Cell Biol. 2016 Apr 11;213(1):97-108
pubmed: 27044892
Nature. 2002 Nov 7;420(6911):74-8
pubmed: 12422217
Methods Mol Med. 2006;129:267-78
pubmed: 17085817
Cell Death Dis. 2019 Jul 15;10(8):539
pubmed: 31308359
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
J Neurosci. 2009 May 6;29(18):5768-83
pubmed: 19420245
Elife. 2016 Jan 27;5:e10130
pubmed: 26821125
Urol Clin North Am. 1999 May;26(2):281-90
pubmed: 10361551
Curr Biol. 2013 Nov 18;23(22):2288-2295
pubmed: 24210614
Mol Cancer Res. 2017 Jul;15(7):875-883
pubmed: 28314844
Int J Lab Hematol. 2021 Dec;43(6):1472-1482
pubmed: 34216518
Science. 2017 Jan 6;355(6320):78-83
pubmed: 28059767
J Clin Oncol. 2018 Aug 20;36(24):2492-2503
pubmed: 29985747
Cancer Res. 2016 Sep 1;76(17):5163-74
pubmed: 27450452
Clin Cancer Res. 2019 Dec 1;25(23):6916-6924
pubmed: 31363002
EMBO J. 2003 Jul 1;22(13):3291-302
pubmed: 12839991
Clin Cancer Res. 1998 Nov;4(11):2625-34
pubmed: 9829725
J Cell Biol. 2008 May 5;181(3):439-46
pubmed: 18458155
J Clin Invest. 2019 Jul 30;129(10):4492-4505
pubmed: 31361600
Nat Neurosci. 2004 Mar;7(3):221-8
pubmed: 14966521
Prostate. 2020 Feb;80(3):256-266
pubmed: 31856338
Nat Commun. 2017 Dec 7;8(1):1988
pubmed: 29215016
J Biol Chem. 2012 Jul 13;287(29):24585-94
pubmed: 22648415
J Extracell Vesicles. 2020 May 20;9(1):1763594
pubmed: 32595914
Blood. 2011 May 5;117(18):4978-87
pubmed: 21378273
J Cell Biol. 2003 Jul 21;162(2):233-43
pubmed: 12860969
J Neurosci. 2005 Jan 26;25(4):808-22
pubmed: 15673660
Clin Cancer Res. 2014 Jun 1;20(11):2846-50
pubmed: 24727321
PLoS One. 2021 Jan 22;16(1):e0244985
pubmed: 33481853
Am J Clin Exp Urol. 2014 Dec 09;2(4):273-85
pubmed: 25606573
Mol Endocrinol. 2012 May;26(5):716-35
pubmed: 22456196
J Natl Cancer Inst. 2010 Jan 20;102(2):107-18
pubmed: 20068194
J Neurochem. 2003 May;85(3):717-28
pubmed: 12694398
Protein Sci. 2011 Apr;20(4):684-9
pubmed: 21308849
Cell. 2003 Apr 4;113(1):37-47
pubmed: 12679033
Cancers (Basel). 2021 Apr 04;13(7):
pubmed: 33916607
Cancer Discov. 2011 Nov;1(6):487-95
pubmed: 22389870
Genes Dev. 2008 May 15;22(10):1325-30
pubmed: 18483218
Neoplasia. 2013 Jan;15(1):1-10
pubmed: 23358695
Oncogene. 2019 Dec;38(50):7447-7456
pubmed: 31427738
PLoS One. 2009;4(4):e5218
pubmed: 19367338
Cancer Res. 1999 Apr 1;59(7):1655-64
pubmed: 10197643
Nat Med. 2016 Mar;22(3):298-305
pubmed: 26855148
JCI Insight. 2021 Apr 22;6(8):
pubmed: 33724955
Brain. 2021 Mar 3;144(2):636-654
pubmed: 33479772
Nat Rev Cancer. 2010 Jan;10(1):9-22
pubmed: 20029421
Neuron. 1994 Sep;13(3):757-67
pubmed: 7522484
J Neurosci. 2014 Jan 29;34(5):1633-46
pubmed: 24478347
Matrix Biol. 2019 Apr;77:41-57
pubmed: 30098419
Trends Neurosci. 2008 May;31(5):221-6
pubmed: 18394723
Mol Med Rep. 2017 Aug;16(2):2030-2036
pubmed: 28656312
Oncogene. 2006 Sep 28;25(44):5942-52
pubmed: 16652149
Cancer Res. 2017 Sep 15;77(18):5129-5141
pubmed: 28687620
J Biol Chem. 2010 Oct 1;285(40):30370-4
pubmed: 20702409
Cancer Res. 2003 Mar 15;63(6):1359-64
pubmed: 12649199
Nat Cancer. 2021 Dec;2(12):1387-1405
pubmed: 34957415
J Extracell Vesicles. 2020 May 24;9(1):1761072
pubmed: 32922691
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1205-10
pubmed: 15647357
Mol Cell Neurosci. 1996 Feb;7(2):89-101
pubmed: 8731478
Prostate. 2017 May;77(6):654-671
pubmed: 28156002

Auteurs

Fabio Quaglia (F)

Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.
Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.

Shiv Ram Krishn (SR)

Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.
Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.

Khalid Sossey-Alaoui (K)

Department of Medicine, School of Medicine, MetroHealth Medical Center, Rammelkamp Center for Research, Case Western Reserve University, Cleveland, OH, USA.

Priyanka Shailendra Rana (PS)

Department of Medicine, School of Medicine, MetroHealth Medical Center, Rammelkamp Center for Research, Case Western Reserve University, Cleveland, OH, USA.

Elzbieta Pluskota (E)

Cardiovascular and Metabolic Sciences Department, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Pyung Hun Park (PH)

Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.
Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.

Christopher D Shields (CD)

Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.
Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.

Stephen Lin (S)

Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA.
Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.

Peter McCue (P)

Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA.

Andrew V Kossenkov (AV)

Center for Systems and Computational Biology, Wistar Institute, Philadelphia, PA, USA.

Yanqing Wang (Y)

Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

David W Goodrich (DW)

Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Sheng-Yu Ku (SY)

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

Himisha Beltran (H)

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

William K Kelly (WK)

Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.

Eva Corey (E)

Department of Urology, University of Washington, Seattle, WA, USA.

Maja Klose (M)

Institute of Neurochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.

Christine Bandtlow (C)

Institute of Neurochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.

Qin Liu (Q)

Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.

Dario C Altieri (DC)

Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA.

Edward F Plow (EF)

Cardiovascular and Metabolic Sciences Department, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Lucia R Languino (LR)

Prostate Cancer Discovery and Development Program, Thomas Jefferson University, Philadelphia, PA, USA. lucia.languino@jefferson.edu.
Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA. lucia.languino@jefferson.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH